Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
Published
Nov 14, 2022
Fam, A., Finger, P. T., Tomar, A. S., Garg, G., & Chin, K. J. (2020). Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study. Indian Journal of Ophthalmology, 68(11), 2439.
This study suggests that the use of HOCL 0.01% spray after Betadine® 5% for IVI prophylaxis will offer improved patient comfort as a rinse for Betadine®. The known spectrum of antiseptic coverage provided by HOCL 0.01% spray was equal to or better than Betadine®, and affects the majority of the pathogens commonly implicated in endophthalmitis. This research reports on the novel use of HOCL 0.01% as an ocular surface antiseptic.
LEADING THE WAY IN HOCL FOR HEALTHCARE
At BIHOCL, we are passionate about our formulations and energized by our commitment to make a difference in people’s lives and in the world.